RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search

… (HARMONY 1 trial): 52‐week primary endpoint results from a randomized, double‐blind, placebo‐controlled trial in patients with type 2 diabetes mellitus not controlled …

Aims To show that albiglutide, a glucagon‐like peptide‐1 receptor agonist, is an effective and generally safe treatment to improve glycaemic control in patients with type 2 diabetes …..... Read More